Biological significance of endogenous methylarginines that inhibit nitric oxide synthases

Cardiovascular Research

Volumn 43, Issue 3, 1999, Pages 542-548

  Leiper, James ^a   Vallance, Patrick ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Dimethylarginine dimethylaminohydrolase; Methylarginine; Nitric oxide synthase

Indexed keywords

ARGININE; N(G) METHYLARGININE; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTEIN INHIBITOR;

BIOSYNTHESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; DOSE RESPONSE; DRUG ACTIVITY; ENDOTHELIUM CELL; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; MOLECULAR BIOLOGY; MOLECULAR MODEL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; REVIEW;

AMIDOHYDROLASES; ANIMALS; ARGININE; CYTOSOL; ENZYME INHIBITORS; HUMANS; HYDROLASES; ISOENZYMES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PROTEIN-ARGININE N-METHYLTRANSFERASE;

EID: 0033566683     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(99)00162-5     Document Type: Review

References (54)

1. Drapier J.C., Hibbs J.B. Murine cytotoxic activated macrophages inhibit aconitase in tumor cells-inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest. 78:1986;790-797.
2. Palmer R.M.J., Ferrige A.G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
3. Palmer R.M.J., Ashton D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1988;664-666.
4. Aisaka K., Gross S.S., Griffith O.W., Levi R.N.G. methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig. Does nitric oxide regulate blood pressure in vivo. Biochem Biophys Res Commun. 160:1989;881-886.
5. Rees D.D., Palmer R.M.J., Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA. 86:1989;3375-3378.
6. Vallance P., Collier J., Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 8670:1989;997-1000.
7. Petros A., Lamb G., Leone A., et al. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res. 28:1994;34-39.
8. Baldwin G.S., Carnegie P.R. Specific enzymic methylation of an arginine in the experimental allergic encephalomyelitis protein from human myelin. Science. 171:1971;579-580.
9. Wang C., Lazarides E., O'Connor C.M., Clarke S. Methylation of chicken fibroblast heat shock proteins at lysyl and arginyl residues. J Biol Chem. 257:1982;8356-8362.
10. G-dimethylarginine. J Biol Chem. 260:1985;14304-14310.
11. G dimethylarginine in nucleolar protein C23. Biochemistry. 22:1985;6025-6028.
12. Paik W.K., Kim S. Protein methylase 1. Purification and properties of the enzyme. J Biol Chem. 243:1968;2108-2114.
13. Ghosh S.K., Woon K.P., Kim S. Purification and molecular identification of two protein methylases I from calf brain. Myelin basic protein- and histone-specific enzymes. J Biol Chem. 263:1988;19024-19033.
14. Najbauer J., Johnson B.A., Young A.L., Aswad D.W. Peptides with sequences similar to glycine, arginine-rich motifs in proteins interacting with RNA are efficiently recognized by methyltransferases modifying arginine in numerous proteins. J Biol Chem. 268:1993;10501-10509.
15. Rajpurohit R., Paik W.K., Kim S. Enzymatic methylation of heterogenous nuclear ribonucleoprotein in isolated liver nuclei. Biochim Biophys Acta. 1122:1992;183-188.
16. Lin W.-J., Gary J.D., Melody C.Y., et al. The mammalian intermediate-early TIS21 protein and the leukemia-associated BTG1 protein interact with a protein-arginine N-methyltransferase. J Biol Chem. 271:1996;15034-15044.
17. Abramovich C., Yakobson B., Chebath J., Revel M. A protein-arginine methyltransferase binds to the intracytoplasmic domain of the IFNAR1 chain in the type I interferon receptor. EMBO J. 16:1997;260-266.
18. Katsanis N., Yaspo M.L., Fisher E.M. Identification and mapping of a novel human gene, HRMT1L1, homologous to the rat protein arginine N-methyltransferase 1 (PRMT1) gene. Mamm Genome. 8:1997;526-529.
19. Tang J., Gray J.D., Clarke S., Herschman H.R. PRMT 3, a type I protein arginine N-methyltransferase that differs from PRMT1 in its oligomerization, subcellular localization, substrate specificity and regulation. J Biol Chem. 273:1998;16935-16945.
20. Clarke S. Protein methylation. Curr Opin Cell Biol. 5:1993;977-983.
21. G′-dimethylarginine, N-epsilon-mono-, di-, and trimethyllysine, and glucosylgalactosyl- and galactosyl-delta-hydroxylysine from human urine. J Biol Chem. 245:1970;5751-5758.
22. Young V.R., Alexis S.D., Baliga B.S., et al. Metabolism of administered 3-methylhistidine. Lack of muscle transfer ribonucleic acid charging and quantitative excretion as 3-methylhistidine and its N-acetyl derivative. J Biol Chem. 247:1972;3592-3600.
23. G′-dimethylarginine in rats. Arch Biochem Biophys. 252:1987;526-537.
24. G-dimethylarginine dimethylaminohydrolase, from rat kidney. J Biol Chem. 264:1989;10205-10209.
25. G-dimethylarginine dimethylaminohydrolase in the nitric oxide generating systems of rats using a monoclonal antibody. Arch Biochem Biophys. 300:1993;657-662.
26. MacAllister R.J., Parry H., Kimoto M., et al. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. Br J Pharmacol. 119:1996;1533-1540.
27. Vallance P., Leone A., Calver A., et al. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 339:1992;572-575.
28. G-monomethylarginine uptake - a mechanism for differential inhibition of NO synthases. Am J Physiol. 269:1995;C750-C765.
29. Malandro M.S., Kilberg M.S. Molecular biology of mammalian amino acid transporters. Annu Rev Biochem. 65:1996;305-336.
30. McDonald K.K., Zharikov S., Block E.R., Kilberg M.S. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric oxide synthase may explain the 'arginine paradox'. J Biol Chem. 272:1997;31213-31216.
31. MacAllister R.J., Vallance P. Nitric oxide in essential and renal hypertension. J Am Soc Nephrol. 5:1994;1057-1065.
32. G-methyl-L-arginine functions as an alternative substrate and mechanism-based inhibitor of nitric oxide synthase. Biochemistry. 32:1993;9677-9685.
33. MacAllister R.J., Whitley G.St.J., Vallance P. Effects of guanidino and uremic compounds on nitric oxide pathways. Kidney Int. 45:1994;737-742.
34. Cayatte A.J., Palacino J.J., Horten K., Cohen R.A. Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb. 14:1994;753-759.
35. MacAllister R.J., Vallance P. Endogenous inhibitors of nitric oxide synthesis: How important are they? Exp Nephrol. 6:1997;195-199.
36. Baydoun A.R., Emery P.W., Pearson J.D., Mann G.E. Substrate-dependent regulation of intracellular amino acid concentrations in cultured bovine aortic endothelial cells. Biochem Biophys Res Commun. 173:1990;940-948.
37. Cooke J.P., Andon N.A., Girerd X.J., et al. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta. Circulation. 83:1991;1057-1062.
38. Arnal J.F., Munzel T., Venema R.C., et al. Interactions between L-arginine and L-glutamine change endothelial NO production. An effect independent of NO synthase substrate availability. J Clin Invest. 95:1995;2565-2572.
39. Lui J., Garcia-Cardena G., Sessa W.C. Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry. 35:1996;13277-13281.
40. MacAllister R.J., Rambausek M.H., Vallance P., et al. Concentration of dimethyl-L-arginine in the plasma of patients with end-stage renal failure. Nephrol Dial Transplant. 11:1996;2449-2452.
41. Arese M., Strasly M., Ruva C., et al. Regulation of nitric oxide synthesis in uremia. Nephrol Dial Transplant. 10:1995;1386-1397.
42. Goonasekera C.D.A., Rees D.D., Woolard P., et al. Nitric oxide synthase inhibitors and hypertension in children and adolescents. J Hypertens. 15:1997;901-909.
43. Bode-Boger S.M., Boger R.H., Kienke S., et al. Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun. 219:1996;598-603.
44. Boger R.H., Bode-Boger S.M., Szuba A., et al. Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction. Its role in hypercholesterolemia. Circulation. 98:1998;1842-1847.
45. Azuma H., Sato J., Hamasaki H., et al. Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells. Br J Pharmacol. 115:1995;1001-1004.
46. Herlitz H., Petersson A., Sigstrom L., et al. The arginine-nitric oxide pathway in thrombotic microangiopathy. Scand J Urol Nephrol. 31:1997;477-479.
47. Marescau B., Nagels G., Possemiers I., et al. Guaidino compounds in serum and urine of non-dialyzed patients with chronic renal insufficiency. Metabolism. 46:1997;1024-1031.
48. G-dimethylarginine in human plasma by high performance liquid chromatography. J Chromatogr B. 692:1997;467-471.
49. Matsuoka H., Itoh S., Kimoto M., et al. Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension. 29:1997;242-247.
50. Boger R.H., Bode-Boger S.M., Brandes R.P., et al. Dietary L-arginine reduces the progression of atherosclerosis in cholesterol fed rabbits: comparison with lovastatin. Circulation. 96:1997;1282-1290.
51. Miyazaki H., Matsuoka H., Cooke J.P., et al. Endogenous nitric oxide synthase inhibitor - A novel marker of atherosclerosis. Circulation. 99:1999;1141-1146.
52. Das I., Khan N.S., Puri B.K., Hirsch S.R. Elevated endogenous nitric oxide synthase inhibitor in schizophrenic plasma may reflect abnormalities in brain nitric oxide production. Neurosci Lett. 215:1996;209-211.
53. Fandriks L., von-Bothmer C., Johansson B., et al. Water extract of Helicobacter pylori inhibits duodenal mucosal alkaline secretion in anesthetized rats. Gastroenterology. 113:1997;1570-1575.
54. Masuda H., Goto M., Tamaoki S., Azuma H. Accelerated intimal hyperplasia and increased endogenous inhibitors for NO synthesis in rabbits with alloxan-induced hyperglycaemia. Br J Pharmacol. 126:1999;211-218.